A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer-Reference-Cited by-同舟云学术

A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer

Published:2020-07-07 Issue:2 Volume:275 Page:391-397
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Hank Thomas,Sandini Marta,Ferrone Cristina R.,Ryan David P.,Mino-Kenudson Mari,Qadan Motaz,Wo Jennifer Y.,Klaiber Ulla,Weekes Colin D.,Weniger Maximilian,Hinz Ulf,Harrison Jon M.,Heckler Max,Warshaw Andrew L.,Hong Theodore S.,Hackert Thilo,Clark Jeffrey W.,Büchler Markus W.,Lillemoe Keith D.,Strobel Oliver,Castillo Carlos Fernández-del

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference47 articles.

1. Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis;Janssen;J Natl Cancer Inst,2019

2. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis;Suker;Lancet Oncol,2016

3. Optimizing the outcomes of pancreatic cancer surgery;Strobel;Nat Rev Clin Oncol,2019

4. Prediction models in cancer care;Vickers;CA Cancer J Clin,2011

5. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers;Chun;Ann Surg Oncol,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapie des Pankreaskarzinoms: Innovative Chirurgie und moderne Systemtherapien;Deutsches Ärzteblatt Online;2024-09-06

2. Failure to rescue following oesophagectomy in Australia: a multi‐site retrospective study using American College of Surgeons National Surgical Quality Improvement Program;ANZ Journal of Surgery;2024-04-22

3. Intraoperative strategies and techniques to achieve surgical radicality in pancreatic cancer;European Surgery;2024-04-12

4. Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer;European Journal of Cancer;2023-11

5. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma;BMC Cancer;2023-08-23